Pharma

Dr Reddy

eHEALTH Bureau

dIgitalhealth

Dr Reddy’s Laboratories has recently announced that it will be launching Lansoprazole delayed-release capsules (15 mg and 30 mg), a bioequivalent generic version of Prevacid Delayed-Release Capsules, in the US market. The Food & Drug Administration (FDA) approved Dr Reddy’s ANDA for Lansoprazole delayed-release capsules on October 15, 2010. Launch preparations are complete and shipments will commence shortly.

Dr Reddy’s Lansoprazole delayed-release capsules are available in bottles of 30 & 90 counts in 15mg and 90 and 500 counts in 30 mg.

Established in 1984, Dr Reddy’s Laboratories is a global pharmaceutical company fulfilling the purpose of providing affordable and innovative medicines through three core businesses: Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. The products are marketed globally, with a focus on India, US, UK, Germany and Russia.

dIgitalhealth

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on


Most Popular

SUBSCRIBE OUR NEWSLETTER
200000+ Subscribers read it every day.
Subscribe Newsletter
To Top